Mcrae Capital Management Inc Merck & Co., Inc. Transaction History

Mcrae Capital Management Inc

$452 Million
Q1 2024

A detailed history of Mcrae Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mcrae Capital Management Inc holds 9,195 shares of MRK stock, worth $1.16 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

9,195

Previous 9,337 1.52%

Holding current value

$1.16 Million

Previous $1.02 Million 19.27%

% of portfolio

0.27%

Previous 0.26%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$113.24 - $131.95 $16,080 - $18,736	-142 Reduced 1.52%	9,195 $1.21 Million
Q4 2023 Jan 22, 2024	BUY	$100.18 - $109.02 $15,728 - $17,116	157 Added 1.71%	9,337 $1.02 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $35,620 - $39,558	-346 Reduced 3.63%	9,180 $945,000
Q2 2023 Jul 21, 2023	BUY	$108.61 - $118.38 $4,127 - $4,498	38 Added 0.4%	9,526 $1.1 Million
Q1 2023 Apr 19, 2023	SELL	$102.94 - $114.86 $3,705 - $4,134	-36 Reduced 0.38%	9,488 $1.01 Million

Q4 2022 Jan 20, 2023	BUY	$87.44 - $112.11 $8,219 - $10,538	94 Added 1.0%	9,524 $0
Q3 2022 Oct 20, 2022	BUY	$84.53 - $94.96 $23,752 - $26,683	281 Added 3.07%	9,430 $812,000
Q2 2022 Jul 20, 2022	BUY	$83.49 - $94.64 $31,642 - $35,868	379 Added 4.32%	9,149 $834,000
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $104,090 - $116,678	1,416 Added 19.25%	8,770 $720,000
Q4 2021 Jan 26, 2022	BUY	$72.28 - $90.54 $13,154 - $16,478	182 Added 2.54%	7,354 $564,000
Q3 2021 Oct 26, 2021	SELL	$71.68 - $78.83 $18,851 - $20,732	-263 Reduced 3.54%	7,172 $539,000
Q2 2021 Jul 28, 2021	SELL	$70.31 - $77.77 $1,617 - $1,788	-23 Reduced 0.31%	7,435 $578,000
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $28,645 - $33,741	416 Added 5.91%	7,458 $575,000
Q4 2020 Jan 27, 2021	BUY	$71.77 - $79.65 $29,210 - $32,417	407 Added 6.13%	7,042 $576,000
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $7,683 - $8,709	105 Added 1.61%	6,635 $550,000
Q2 2020 Jul 23, 2020	SELL	$70.42 - $80.13 $18,450 - $20,994	-262 Reduced 3.86%	6,530 $505,000
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $253 - $351	4 Added 0.06%	6,792 $523,000
Q4 2019 Jan 17, 2020	SELL	$77.58 - $87.54 $15,205 - $17,157	-196 Reduced 2.81%	6,788 $617,000
Q3 2019 Oct 21, 2019	BUY	$76.08 - $82.93 $9,357 - $10,200	123 Added 1.79%	6,984 $588,000
Q2 2019 Jul 29, 2019	BUY	$69.84 - $81.59 $49,167 - $57,439	704 Added 11.43%	6,861 $575,000
Q1 2019 Apr 16, 2019	SELL	$69.58 - $79.36 $3,548 - $4,047	-51 Reduced 0.82%	6,157 $512,000
Q4 2018 Jan 28, 2019	BUY	$65.24 - $75.71 $24,138 - $28,012	370 Added 6.34%	6,208 $474,000
Q3 2018 Oct 15, 2018	SELL	$57.69 - $67.84 $10,384 - $12,211	-180 Reduced 2.99%	5,838 $414,000
Q2 2018 Jul 16, 2018	SELL	$50.83 - $59.72 $89,714 - $105,405	-1,765 Reduced 22.68%	6,018 $365,000
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $112,876 - $131,194	2,215 Added 39.78%	7,783 $424,000
Q3 2017 Oct 23, 2017	BUY	$58.67 - $63.13 $326,674 - $351,507	5,568	5,568 $357,000

Others Institutions Holding MRK

# of Institutions

3,770

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Merck & Co., Inc. Transaction History